Business Description
Poolbeg Pharma PLC
ISIN : GB00BKPG7Z60
Share Class Description:
POLBF: Ordinary SharesDescription
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.96 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 0.03 | |||||
| 6-1 Month Momentum % | -32.57 | |||||
| 12-1 Month Momentum % | 10.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.61 | |||||
| Quick Ratio | 19.61 | |||||
| Cash Ratio | 17.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -30.23 | |||||
| ROA % | -28.86 | |||||
| ROIC % | -163.86 | |||||
| ROCE % | -35.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.06 | |||||
| Price-to-Tangible-Book | 2.36 | |||||
| EV-to-EBIT | -3.06 | |||||
| EV-to-Forward-EBIT | -2.41 | |||||
| EV-to-EBITDA | -3.07 | |||||
| EV-to-Forward-EBITDA | -2.41 | |||||
| EV-to-FCF | -3.44 | |||||
| Price-to-Net-Current-Asset-Value | 2.36 | |||||
| Price-to-Net-Cash | 2.36 | |||||
| Earnings Yield (Greenblatt) % | -32.68 | |||||
| FCF Yield % | -17.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:POLBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Poolbeg Pharma PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.011 | ||
| Beta | 0 | ||
| Volatility % | 60.71 | ||
| 14-Day RSI | 0.03 | ||
| 14-Day ATR ($) | 0.00009 | ||
| 20-Day SMA ($) | 0.118 | ||
| 12-1 Month Momentum % | 10.28 | ||
| 52-Week Range ($) | 0.107 - 0.2269 | ||
| Shares Outstanding (Mil) | 500 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Poolbeg Pharma PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Poolbeg Pharma PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Poolbeg Pharma PLC Frequently Asked Questions
What is Poolbeg Pharma PLC(POLBF)'s stock price today?
The current price of POLBF is $0.12. The 52 week high of POLBF is $0.23 and 52 week low is $0.11.
When is next earnings date of Poolbeg Pharma PLC(POLBF)?
The next earnings date of Poolbeg Pharma PLC(POLBF) is 2025-04-30 Est..
Does Poolbeg Pharma PLC(POLBF) pay dividends? If so, how much?
Poolbeg Pharma PLC(POLBF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers